Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Sheep toxin could be linked to MS
“There is a growing body of wider evidence that points to a hypothesis linking MS and ETX".

Discovery could lead to new tests and treatments 

Scientists say exposure to a toxin found in sheep could be linked to the development of multiple sclerosis (MS) in humans.

A study by the University of Exeter and MS Sciences Ltd found that people with MS are more likely to have antibodies against the epsilon toxin (ETX), which suggests they have been exposed to it at some point.

ETX is produced in the gut of livestock by the bacterium, Clostridium perfringens. Whilst it can occur in other animals and even soil, it has primarily been studied as a cause of enterotoxaemia in sheep.

Researchers found 43 per cent of patients with MS were positive for antibodies to ETX, compared to 16 per cent of healthy participants.

Simon Slater, director of MS Sciences Ltd, said: “There is a growing body of wider evidence that points to a hypothesis linking MS and ETX, and we are confident that these significant findings from our latest study will help people get even closer to an answer for the elusive triggers of MS”.

If the link is proven, it would suggest that a vaccine could prevent MS in the early stages of the disease, Slater added.

However, the causes of the disease are not yet fully understood and further research is needed to understand how ETX may be involved in MS and how such findings could be used to develop tests or treatments.

MS is most commonly diagnosed in patients in their 20s and 30s and can affect the brain, causing a wide range of symptoms including problems with vision, movement, sensation and balance. It is estimated that more than a 100,000 people in the UK are diagnosed with MS.

The full research paper is published in the Multiple Sclerosis Journal: Click here

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.